Skip to main content
Dr Layloma Rashid avatar
Reviewed profileID verifiedEEAT
StocksAI

TECHi author

Dr Layloma Rashid

News Writer

@layloma

Stories

417

419K total views

Author score

64

Profile reviewed

First story

July 23, 2025

Member since June 28, 2025

Dr Layloma Rashid brings a clinical lens to healthcare investing. She translates FDA filings, Phase 3 readouts, and PDUFA calendar dates into analysis readers can act on — covering large-cap pharma, medical-device makers, and the oncology and GLP-1 pipelines reshaping the sector. Her coverage weighs ClinicalTrials.gov data against management guidance and flags where sell-side models diverge from what trial design actually supports. She writes about drug development with the skepticism Phase 2 success rates deserve.

Sign in for alertsGet email alerts when Dr publishes new reports.

Track record

Measured from Dr Layloma Rashid's published work and editorial quality signals. Scores are 0–100; unmeasured signals are simply not shown.

417 published · 418.9K views

Author ScoreBuilding
64/100

TECHi's composite score — blends output volume, community ratings, fact-check accuracy, identity verification, and profile completeness.

OutputExcellent
100/100

Publishing cadence and volume normalized over time. Rewards consistent output without overweighting prolific drive-bys.

IdentityExcellent
100/100

Filled profile sections: headline, bio, avatar, social links, expertise, location. Higher = better reader context.

Profile completenessBuilding
57/100

How complete the public profile is: bio, headline, photo, expertise and verified links.

Field confirmed

0

Facts that community fact-checkers reviewed and confirmed as accurate. A dash means this signal is not tracked yet.

⚠︎

Accepted corrections

0

Approved corrections tied to this author in TECHi's public corrections log. Zero means no approved public correction is on record.

Revisions shipped

0

Post-publish updates the author submitted and an editor approved. Signals active stewardship of evergreen content.

TECHi Reviewed Author ProfileID VerifiedE-E-A-T profile complete

Beat map

Markets & Equities9
AI & Intelligence6
Tech Breakthroughs2
Policy & Impact1

Publishing cadence

Output over 12 months

18 articles across 6 active months.

10
1
3
1
2
1
OctNovDecJanFebMarAprMayJunJulAugSep

Lead story

Most recent publish - open the full analysis or scroll for the full archive.

Archive

Latest analysis

Stocks, crypto, AI, and policy - reporting and commentary on TECHi (showing 18 of 308).

Legacy archive

Pre-pivot work

7 articles from Dr Layloma Rashid's earlier editorial era on TECHi. These remain available at their original URLs but aren't part of the current beat.

Topic mix

Coverage breakdown

Where Dr's recent stories cluster — jump into a desk.